Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B-Reference-Cited by-同舟云学术

Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B

Published:1998-09 Issue:3 Volume:29 Page:345-351
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Alexopoulou Alexandra,Owsianka Ania M.,Kafiri Georgia,Dourakis Spyros P.,Carman William F.,Hadziyannis Stephanos J.

Publisher

Elsevier BV

Subject

Hepatology

Reference32 articles.

1. Immunopathogenesis and natural course of anti-HBe positive chronic hepatitis and natural course of anti-HBe positive chronic hepatitis with replicating B virus;Hadziyannis,1991

2. Mutation preventing formation of hepatitis B antigen in patients with chronic hepatitis B infection;Carman;Lancet,1989

3. Natural course and response to interferon of chronic hepatits B accompanied by antibody to hepatitis B e antigen;Brunetto;Hepatology,1989

4. Interferon alfa-2b treatment of HBeAG negative/serum positive chronic active hepatitis type B;Hadziyannis;J Hepatol,1990

5. Hepatitis B precore/core variation and interferon therapy;Fattovich;Hepatology,1995

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection;World Journal of Gastroenterology;2014

2. Core mutations in patients with acute episodes of chronic HBV infection are associated with the emergence of new immune recognition sites and the development of high IgM anti-HBc index values;Journal of Medical Virology;2008-11-21

3. Diagnosis and management of pre-core mutant chronic hepatitis B;Journal of Viral Hepatitis;2001-09

4. Geography Unbound: French Geographic Science from Cassini to Humboldt. By Anne Marie Claire Godlewska (Chicago, University of Chicago Press, 2000) 444 pp., $65.00 cloth, $27.50 paper;The Journal of Interdisciplinary History;2001-04

5. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B;Hepatology;2000-03